Natalizumab discontinuation: an increasingly tricky proposition

T.W. West, J. Killestein, R.J. Fox

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	663-664
Journal	European Journal of Neurology
Volume	19
Issue number	5
DOIs	https://doi.org/10.1111/j.1468-1331.2011.03574.x
Publication status	Published - 2012

Cite this

@article{c6358b10f8b8497bbcb4cbbd397e47fa,

title = "Natalizumab discontinuation: an increasingly tricky proposition",

author = "T.W. West and J. Killestein and R.J. Fox",

year = "2012",

doi = "10.1111/j.1468-1331.2011.03574.x",

language = "Undefined/Unknown",

volume = "19",

pages = "663--664",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Natalizumab discontinuation: an increasingly tricky proposition

AU - West, T.W.

AU - Killestein, J.

AU - Fox, R.J.

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1468-1331.2011.03574.x

DO - 10.1111/j.1468-1331.2011.03574.x

M3 - Article

C2 - 22054207

VL - 19

SP - 663

EP - 664

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 5

ER -